ALĞIN, E. Et Al. 2004. Effects of the polymer type, polymer:direct tabletting agent ratio and tabletting mechanism on Verapamil HCl extended release from hydroxypropylmethylcellulose matrix tablets. ACTA FARMACEUTICA BONAERENSE , vol.33, no.3 , 125-137.

ALĞIN, E., KILIÇARSLAN, M., KARATAŞ, A., YÜKSEL, N., & BAYKARA, T., (2004). Effects of the polymer type, polymer:direct tabletting agent ratio and tabletting mechanism on Verapamil HCl extended release from hydroxypropylmethylcellulose matrix tablets. ACTA FARMACEUTICA BONAERENSE , vol.33, no.3, 125-137.

ALĞIN, EVREN Et Al. "Effects of the polymer type, polymer:direct tabletting agent ratio and tabletting mechanism on Verapamil HCl extended release from hydroxypropylmethylcellulose matrix tablets," ACTA FARMACEUTICA BONAERENSE , vol.33, no.3, 125-137, 2004

ALĞIN, EVREN A. Et Al. "Effects of the polymer type, polymer:direct tabletting agent ratio and tabletting mechanism on Verapamil HCl extended release from hydroxypropylmethylcellulose matrix tablets." ACTA FARMACEUTICA BONAERENSE , vol.33, no.3, pp.125-137, 2004

ALĞIN, E. Et Al. (2004) . "Effects of the polymer type, polymer:direct tabletting agent ratio and tabletting mechanism on Verapamil HCl extended release from hydroxypropylmethylcellulose matrix tablets." ACTA FARMACEUTICA BONAERENSE , vol.33, no.3, pp.125-137.

@article{article, author={EVREN ALĞIN YAPAR Et Al. }, title={Effects of the polymer type, polymer:direct tabletting agent ratio and tabletting mechanism on Verapamil HCl extended release from hydroxypropylmethylcellulose matrix tablets}, journal={ACTA FARMACEUTICA BONAERENSE}, year=2004, pages={125-137} }